These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1621633)

  • 1. Peptic ulcer disease.
    Ebell MH
    Am Fam Physician; 1992 Jul; 46(1):217-27. PubMed ID: 1621633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
    Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
    Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in the pharmacotherapy for peptic ulcer disease.
    Hixson LJ; Kelley CL; Jones WN; Tuohy CD
    Arch Intern Med; 1992 Apr; 152(4):726-32. PubMed ID: 1558429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
    Jost C; Marbet UA
    Schweiz Med Wochenschr; 1998 Jan; 128(3):64-71. PubMed ID: 9498257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peptic ulcer, Helicobacter pylori].
    Bauerfeind P; Wirth HP
    Ther Umsch; 1997 Nov; 54(11):624-8. PubMed ID: 9454363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.